Abstract
Alzheimers disease (AD) is characterized by the aggregation and subsequent deposition of misfolded β- amyloid (Aβ) peptide. The unfolded protein response (UPR) is activated by misfolded protein stress in the endoplasmic reticulum (ER). In previous studies we demonstrated mild activation of the UPR by extracellularly applied oligomeric but not fibrillar Aβ1-42. In addition, we showed that oligomeric Aβ1-42 is internalized by cells, whereas fibrillar Aβ1-42 remains on the outside of the cell. Inhibition of Aβ uptake specifically inhibits toxicity of Aβ1-42 oligomers, underscoring the toxic potential of intracellular Aβ. Therefore, in the present study, we investigated the connection between intracellularly produced Aβ and the ER stress response, using human neuroblastoma cells overexpressing either wild type APP695 (APPwt) or APP695V717F (APPmut). Both cell lines secrete higher levels of Aβ1-40 and Aβ1-42 compared to the parental line. In addition, APPmut produces more Aβ1-42 than APPwt. Whereas the basal levels of UPR markers are not different, we find augmented UPR induction in response to ER stress in both APP overproducing cell lines compared to the parental cell line, with the strongest UPR activation in APPmut cells. In addition, ER stress toxicity was highest in APPmut cells, strongly suggesting a connection with the production of Aβ1-42. The difference in ER stress mediated toxicity between the APPwt and APPmut cell lines is alleviated by pretreatment with γ-secretase inhibitor, indicating that it is dependent on Aβ production and in particular on Aβ1-42. Our data indicate that increased Aβ1-42 production sensitizes neuroblastoma cells for ER stress toxicity.
Keywords: Alzheimer's disease, β-Amyloid, intracellular, endoplasmic reticulum, unfolded protein response
Current Alzheimer Research
Title: Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity
Volume: 5 Issue: 5
Author(s): Sidhartha M. Chafekar, Rob Zwart, Robert Veerhuis, H. Vanderstichele, Frank Baas and Wiep Scheper
Affiliation:
Keywords: Alzheimer's disease, β-Amyloid, intracellular, endoplasmic reticulum, unfolded protein response
Abstract: Alzheimers disease (AD) is characterized by the aggregation and subsequent deposition of misfolded β- amyloid (Aβ) peptide. The unfolded protein response (UPR) is activated by misfolded protein stress in the endoplasmic reticulum (ER). In previous studies we demonstrated mild activation of the UPR by extracellularly applied oligomeric but not fibrillar Aβ1-42. In addition, we showed that oligomeric Aβ1-42 is internalized by cells, whereas fibrillar Aβ1-42 remains on the outside of the cell. Inhibition of Aβ uptake specifically inhibits toxicity of Aβ1-42 oligomers, underscoring the toxic potential of intracellular Aβ. Therefore, in the present study, we investigated the connection between intracellularly produced Aβ and the ER stress response, using human neuroblastoma cells overexpressing either wild type APP695 (APPwt) or APP695V717F (APPmut). Both cell lines secrete higher levels of Aβ1-40 and Aβ1-42 compared to the parental line. In addition, APPmut produces more Aβ1-42 than APPwt. Whereas the basal levels of UPR markers are not different, we find augmented UPR induction in response to ER stress in both APP overproducing cell lines compared to the parental cell line, with the strongest UPR activation in APPmut cells. In addition, ER stress toxicity was highest in APPmut cells, strongly suggesting a connection with the production of Aβ1-42. The difference in ER stress mediated toxicity between the APPwt and APPmut cell lines is alleviated by pretreatment with γ-secretase inhibitor, indicating that it is dependent on Aβ production and in particular on Aβ1-42. Our data indicate that increased Aβ1-42 production sensitizes neuroblastoma cells for ER stress toxicity.
Export Options
About this article
Cite this article as:
Chafekar M. Sidhartha, Zwart Rob, Veerhuis Robert, Vanderstichele H., Baas Frank and Scheper Wiep, Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity, Current Alzheimer Research 2008; 5 (5) . https://dx.doi.org/10.2174/156720508785908883
DOI https://dx.doi.org/10.2174/156720508785908883 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient Drug
Current Drug Targets Synthesis of Some Coumarinyl Chalcones and their Antiproliferative Activity Against Breast Cancer Cell Lines
Letters in Drug Design & Discovery Flavonoids as Sirtuin Modulators
Current Topics in Medicinal Chemistry Pleiotropic, Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids
Mini-Reviews in Medicinal Chemistry Synthetic and Natural Coumarins as Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
CNS & Neurological Disorders - Drug Targets Neurokinin-1 Receptor Antagonists as Anticancer Drugs
Letters in Drug Design & Discovery Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms
Current Pharmaceutical Design Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids
Current Neuropharmacology Beneficial Effects of Lysosome-Modulating and Other Pharmacological and Nanocarrier Agents on Amyloid-beta-treated Cells
Current Pharmaceutical Biotechnology The Future of Neuroregenerative Therapy for Parkinson’s Disease
Current Tissue Engineering (Discontinued) Recent Developments in the Formulation of Nanoliposomal Delivery Systems
Current Nanomaterials The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents
Current Medicinal Chemistry Pharmacologic Evidence of Green Tea in Targeting Tyrosine Kinases
Current Reviews in Clinical and Experimental Pharmacology Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters Effects of LPA and S1P on the Nervous System and Implications for Their Involvement in Disease
Current Drug Targets Preclinical Evaluation of no-Carrier-Added [131I]Meta-Iodobenzyl Guanidine, for the Treatment of Tumours Transfected with the Noradrenaline Transporter Gene
Letters in Drug Design & Discovery From Bacteria to Antineoplastic: Epothilones A Successful History
Anti-Cancer Agents in Medicinal Chemistry 1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology
Current Pharmaceutical Design Sera/Organ Lysates of Selected Animals Living in Polluted Environments Exhibit Cytotoxicity against Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry